NHS boards are required to takeaccount of advice and evidence from the Scottish Medicines Consortium (SMC) andensure that recommended medicines are made available to meet clinical need.NHS Scotland has beenadvised of a new strengthened role for SMC and new procedures for ensuring thenational implementation of innovative new drugs.